Joint MHRA/DIA Excellence in Pharmacovigilance London, England, UK 27 February - 3 March, 2017

Description:
This course is designed to provide a firm grounding in key aspects of European Clinical Pre- and Post-Marketing Safety regulatory requirements. This five-day training course also includes highlights and updates on the pharmacovigilance legislation and the latest news on the international harmonisation and standardisation activities in pharmacovigilance.

What you will learn

- Definitions and Methods in Pharmacovigilance
- Regulatory Aspects in Pharmacovigilance and Practial Examples
- Diagnosis of Adverse Drug Reactions
- Signal Detection and Signal Management
- Modern Technologies and Social Media
- Risk Management

Price:
Standard: EUR 3475